U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C7H5N3O2
Molecular Weight 163.1335
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 7-NITROINDAZOLE

SMILES

[O-][N+](=O)C1=CC=CC2=C1NN=C2

InChI

InChIKey=PQCAUHUKTBHUSA-UHFFFAOYSA-N
InChI=1S/C7H5N3O2/c11-10(12)6-3-1-2-5-4-8-9-7(5)6/h1-4H,(H,8,9)

HIDE SMILES / InChI

Molecular Formula C7H5N3O2
Molecular Weight 163.1335
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

7-Nitroindazole (aka 7-NI) is an experimental small molecule that acts as a selective inhibitor of neuronal nitric oxide synthase, which normally converts arginine to citrulline and nitric oxide (NO) in neuronal tissues. It has been investigated for potential use as an anti-nociceptive compound and as a means of mitigating neurodegenerative damage.

CNS Activity

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
0.9 µM [IC50]
3.67 null [pEC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Unknown
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
7-Nitroindazole was administered to mice by intraperitoneal injection in a dose range of 10 - 50 mg/kg. 7-Nitroindazole demonstrated anti-nociceptive effects in the late phase of the formalin-induced hind-paw licking and acetic acid-induced abdominal constriction assays; the ED50 for each assay was 27.5 and 22.5 mg/kg respectively. Maximum antinociceptive activity and NOS inhibition were detected 18-30 min following i.p. administration.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Rabbit aortic rings (with and without endothelium) were mounted for isometric tensile recording in an organ bath containing Krebs solution at 37 deg-C in an atmosphere of 5% CO2. The tissue was placed under an initial tension of 2 g and left to equilibrate for 30 - 45 minutes. Aortic rings were then precontracted with 0.2 micro-M phenylephrine. Once stable contractions were observed, cumulative concentration-effect curves were determined for 7-Nitroindazole (1 micro-M to 1 mM). Concentration-effect curves to 7-Nitroindazole were also determined in rabbit aorta after incubation with the nitric oxide synthase inhibitor L-N^G-nitro arginine p-nitroanilide (50 micro-M) for 60 minutes. The failure of acetylcholine (2 micro-M) to induce relaxation in rabbit aorta was taken as an indication of the absence of a functional endothelium. 7-Nitroindazole caused concentration-dependent relaxations in rabbit aorta with a -log EC50 of 3.67. The relaxant response to 7-Nitroindazole was not significantly different in aortic rings with or without a functional endothelium, or after pretreatment with L-N^G-nitro arginine p-nitroanilide.
Substance Class Chemical
Record UNII
UX0N37CMVH
Record Status Validated (UNII)
Record Version